| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/21/2011 | WO2011044694A1 Blackleg resistance gene |
| 04/21/2011 | WO2011044632A1 Manipulation of flavonoid biosynthetic pathway |
| 04/21/2011 | WO2011044620A1 Epigenetic dna enrichment |
| 04/21/2011 | WO2011015924A3 Vectors and compounds for expression of recombinant trastuzumab |
| 04/21/2011 | WO2011015918A3 Vectors and compounds for expression of recombinant cetuximab |
| 04/21/2011 | WO2011015917A3 Vectors and compounds for expression of recombinant tnk-tpa (tenecteplase) |
| 04/21/2011 | WO2011015916A3 Vectors and compounds for expression of recombinant infliximab |
| 04/21/2011 | WO2011011273A9 The use of dimerization domain component stacks to modulate plant architecture |
| 04/21/2011 | WO2011010792A3 Novel strain of paenibacillus sp. hpl-002 for producing alkaline xylanase, novel xylanase enzyme isolated therefrom, and method for producing same |
| 04/21/2011 | WO2011008545A3 Poly(ester ether amide)s and uses thereof |
| 04/21/2011 | WO2011005978A3 Methods of manipulating cell signaling |
| 04/21/2011 | WO2011005593A3 Schistosomiasis vaccine compositions and methods of use |
| 04/21/2011 | WO2011004962A3 Method for producing l-lysine using corynebacterium sp. that has obtained the activity of glyceraldehyde-3-phosphate dehydrogenase derived from an alien species |
| 04/21/2011 | WO2010147971A3 Il23 modified viral vector for recombinant vaccines and tumor treatment |
| 04/21/2011 | WO2010144324A3 Use of stamp related molecules in the diagnosis and inhibition of ovarian cancer cells |
| 04/21/2011 | WO2010144231A3 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 04/21/2011 | WO2010143917A3 Targeted genomic rearrangements using site-specific nucleases |
| 04/21/2011 | WO2010141953A3 Biomaterials, compositions, and methods |
| 04/21/2011 | WO2010141924A3 Enhanced engineered native promoters and uses thereof |
| 04/21/2011 | WO2010141866A3 Soga polynucleotides and polypeptides and uses thereof |
| 04/21/2011 | WO2010141511A3 Polynucleotides for multivalent rna interference, compositions and methods of use thereof |
| 04/21/2011 | WO2010141471A3 Nucleic acid delivery compositions and methods of use thereof |
| 04/21/2011 | WO2010141391A3 Mutant dna polymerases |
| 04/21/2011 | WO2010138796A3 Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis |
| 04/21/2011 | WO2010138637A3 Fibromodulin peptide |
| 04/21/2011 | WO2010135655A3 Human skin substitutes expressing il-12 |
| 04/21/2011 | WO2010135585A3 Engineered type iv pilin of clostridium difficile |
| 04/21/2011 | WO2010135495A3 Stable, spray dried, immunogenic, viral compositions |
| 04/21/2011 | WO2010134975A3 Methods for enhancing infectivity of retroviruses |
| 04/21/2011 | WO2010132341A3 Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein |
| 04/21/2011 | WO2010129934A3 Methods and compositions for diagnosis of thyroid conditions |
| 04/21/2011 | WO2010129457A3 Vaccines against tularemia |
| 04/21/2011 | WO2010129287A3 Hemicellulose-degrading enzymes |
| 04/21/2011 | WO2010127318A3 Product of fatty acid esters from biomass polymers |
| 04/21/2011 | WO2010127176A3 Methods and compositions for prognosing detecting age-related macular degeneration |
| 04/21/2011 | WO2010122407A8 Hypolipaemic pharmaceutical compositions |
| 04/21/2011 | WO2010114979A3 Radiation therapy biomarkers |
| 04/21/2011 | WO2010111622A3 Amidases and methods of their use |
| 04/21/2011 | WO2010111595A3 Markers related to age-related macular degeneration and uses therefor |
| 04/21/2011 | WO2010105226A3 Endophytic yeast strains, methods for ethanol and xylitol production, methods for biological nitrogen fixation, and a genetic source for improvement of industrial strains |
| 04/21/2011 | WO2010104357A4 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 04/21/2011 | WO2010008588A3 Modulation of gm98 (mrf) in remyelination |
| 04/21/2011 | WO2009110933A3 Engineering enzymatically susceptible phytases |
| 04/21/2011 | WO2008114149A3 Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains |
| 04/21/2011 | WO2008090472A3 Tissue progenitor cells that overexpress erg |
| 04/21/2011 | US20110093985 Transcription factor for promoting lateral root growth under nitrogen-limiting conditions |
| 04/21/2011 | US20110093984 Gene Capable of Being Expressed Specifically in Endosperm of Plant, Promoter for the Gene, and Use of the Gene and the Promoter |
| 04/21/2011 | US20110093983 Algal glycerol-3 phosphate acyltransferase |
| 04/21/2011 | US20110093982 Use of dendrimer nanotechnology for delivery of biomolecules into plant cells |
| 04/21/2011 | US20110093980 Cotton Cultivar L-9009-6 |
| 04/21/2011 | US20110093978 Cotton Cultivar L-403 |
| 04/21/2011 | US20110093977 Cotton Cultivar 856-1 |
| 04/21/2011 | US20110093976 Rice Cultivar CL 181-AR |
| 04/21/2011 | US20110093975 Soybean cultivar s080098 |
| 04/21/2011 | US20110093974 Soybean cultivar s080121 |
| 04/21/2011 | US20110093973 Soybean cultivar s080122 |
| 04/21/2011 | US20110093972 Soybean cultivar s080123 |
| 04/21/2011 | US20110093971 Soybean cultivar s080202 |
| 04/21/2011 | US20110093970 Methods and Means to Modify Fiber Strength in Fiber-Producing Plants |
| 04/21/2011 | US20110093969 Glyphosate tolerant perennial ryegrass named 'replay' |
| 04/21/2011 | US20110093967 Genomically multiplied rapeseed plants, compositions derived therefrom and uses of same |
| 04/21/2011 | US20110093966 Plant height regulatory gene and uses thereof |
| 04/21/2011 | US20110093965 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/21/2011 | US20110093964 Uranium-chelating peptides and uses thereof |
| 04/21/2011 | US20110093961 Mouse lambda light chain locus |
| 04/21/2011 | US20110092688 NUCLEIC ACID CONSTRUCT CONTAINING A NUCLEIC ACID DERIVED FROM THE GENOME OF HEPATITIS C VIRUS (HCV) OF GENOTYPE 2a, AND A CELL HAVING SUCH NUCLEIC ACID CONSTRUCT INTRODUCED THEREIN |
| 04/21/2011 | US20110092673 Isolated Antibodies Against Biologically Active Leptin-Related Peptides |
| 04/21/2011 | US20110092576 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 04/21/2011 | US20110092575 Sirna of human osteopontin |
| 04/21/2011 | US20110092571 Compositions and methods for sirna inhibition of icam-1 |
| 04/21/2011 | US20110092568 Modulation of mlck-l expression and uses thereof |
| 04/21/2011 | US20110092567 Cannabinoid 2 (Cb2) Receptor Gene Promoter and Unique RNA Transcripts in B Cells and Methods of Use |
| 04/21/2011 | US20110092449 Treatment of fibrotic conditions |
| 04/21/2011 | US20110092441 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
| 04/21/2011 | US20110092429 Compositions and methods for producing gamma-carboxylated proteins |
| 04/21/2011 | US20110092424 Production of glucagon like peptide 2 and analogs |
| 04/21/2011 | US20110092422 Elastin based growth factor delivery platform for wound healing and regeneration |
| 04/21/2011 | US20110092417 Leptin fusion proteins |
| 04/21/2011 | US20110092413 Albumin-Fused Kunitz Domain Peptides |
| 04/21/2011 | US20110092411 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 04/21/2011 | US20110092408 Subtilase Variants |
| 04/21/2011 | US20110092391 Phage lambda display constructs |
| 04/21/2011 | US20110092388 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/21/2011 | US20110092386 Isolating biological modulators from biodiverse gene fragment libraries |
| 04/21/2011 | US20110091977 Homologous Recombination in an Algal Nuclear Genome |
| 04/21/2011 | US20110091976 Regulatory region preferentially expressing to seed embryo and method of using same |
| 04/21/2011 | US20110091975 Down-regulation of gene expression using artificial micrornas |
| 04/21/2011 | US20110091974 Conductive Substrate and Method for Introducing Nucleic Acid |
| 04/21/2011 | US20110091973 Modified and fusion enhanced erythrocytes, cells and uses thereof |
| 04/21/2011 | US20110091969 Mutations in the ns5b protein of the hcv |
| 04/21/2011 | US20110091967 Ssx-4 peptides presented by hla class ii molecules |
| 04/21/2011 | US20110091966 Antiviral Peptide Against Hepatitis C Virus |
| 04/21/2011 | US20110091960 Compositions and Methods for Detection of Antibody Binding to Cells |
| 04/21/2011 | US20110091959 Multiply-Substituted Protease Variants |
| 04/21/2011 | US20110091958 Multiply-Substituted Protease Variants |
| 04/21/2011 | US20110091952 Method for enzymatic production of decarboxylated polyketides and fatty acids |
| 04/21/2011 | US20110091928 Agent for Recruitment of Bone-Marrow-Derived Pluripotent Stem Cell Into Peripheral Circulation |
| 04/21/2011 | US20110091921 Novel 12 alpha-hydroxysteroid dehydrogenases, production and use thereof |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091901 Vectors and Methods for Screening Cells for High Expression of Protein of Interest (POI) |